PAR listed as a SELL in today's Herald Sun:
"The drug developer to treat osteoarthritis has seen its stock bounce back strongly but with concerns, such as the quality of its phase 2b trial, positions can be trimmed"
What a load of BS
Ann: NEW FINANCIAL YEAR UPDATE, page-100
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.0¢ | $26.44K | 112.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 148401 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 21091 | 6 |
View Market Depth
| Last trade - 13.00pm 10/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |